Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,690 | -1,470 | -2,730 | -2,670 | -1,910 |
| Depreciation Amortization | 180 | 0 | 1,030 | 1,320 | 1,440 |
| Other Working Capital | 570 | 340 | 1,590 | N/A | N/A |
| Other Operating Activity | 790 | 60 | 40 | 1,870 | 890 |
| Operating Cash Flow | $-2,150 | $-1,070 | $-70 | $520 | $420 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | 0 | -20 | N/A | N/A |
| Net Acquisitions | -80 | 0 | 0 | N/A | N/A |
| Other Investing Activity | 280 | 0 | 0 | 130 | -240 |
| Investing Cash Flow | $190 | $0 | $-20 | $130 | $-240 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,020 | 1,070 | 90 | -660 | -280 |
| Financing Cash Flow | $2,020 | $1,070 | $90 | $-660 | $-280 |
| Exchange Rate Effect | -10 | 0 | 0 | N/A | N/A |
| Beginning Cash Position | 0 | 0 | 0 | N/A | 100 |
| End Cash Position | 50 | 0 | 0 | N/A | 0 |
| Net Cash Flow | $50 | $0 | $0 | $-10 | $-100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,150 | -1,070 | -70 | 520 | 420 |
| Free Cash Flow | -2,150 | -1,070 | -70 | 520 | 420 |